Lindus Health

Executive Summary

Lindus Health, a London-based next-generation Contract Research Organization (CRO) founded in 2021, is disrupting the traditional clinical trial landscape with its all-in-one, technology-enabled platform. By offering transparent fixed pricing and a patient-centric approach, the company aims to accelerate trial timelines and improve data reliability for life sciences companies. As a private entity with limited public financials, Lindus Health has positioned itself as a modern alternative to legacy CROs, leveraging digital tools to streamline site selection, patient recruitment, and trial management. The company's focus on technology-driven efficiency and cost transparency addresses long-standing pain points in clinical development, making it an attractive partner for biotech and pharma firms seeking faster, more predictable trial execution. While still early-stage, Lindus Health's innovative model and founder experience (co-founders previously built successful health tech ventures) suggest strong potential for growth and market share capture in the fragmented CRO industry.

Upcoming Catalysts (preview)

• Q2 2026Series A funding round closing80% success
• Q4 2026Announcement of major pharmaceutical client partnership60% success
• Q1 2027Expansion into US market with new office50% success